Condition: Metastatic Castration-resistant Prostate Cancer · Sponsor: Celgene
The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate Cancer.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Central Alabama Research | Birmingham, Alabama, United States | Recruiting |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| Local Institution - 0370 | Anaheim, California, United States | Completed |
| Moores Cancer Center | La Jolla, California, United States | Recruiting |
| Cancer and Blood Specialty Clinic | Los Alamitos, California, United States | Recruiting |
| Local Institution - 0364 | Los Angeles, California, United States | Withdrawn |
| California Pacific Medical Center | San Francisco, California, United States | Recruiting |
| San Francisco VA Health Care System | San Francisco, California, United States | Recruiting |
| Local Institution - 0458 | Santa Rosa, California, United States | Withdrawn |
| Rocky Mountain Regional VA Medical Center | Aurora, Colorado, United States | Recruiting |
| Rocky Mountain Cancer Centers, LLP | Denver, Colorado, United States | Recruiting |
| Colorado Clinical Research | Lakewood, Colorado, United States | Recruiting |
+ 269 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06764485